Outlook Therapeutics, Inc.·4

Aug 15, 5:16 PM ET

Haller Julia A 4

4 · Outlook Therapeutics, Inc. · Filed Aug 15, 2022

Insider Transaction Report

Form 4
Period: 2022-08-11
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-08-11+25,00025,000 total
    Exercise: $1.15Exp: 2032-08-11Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The options were granted under the Issuer's 2015 Equity Incentive Plan (the "2015 Plan") and shall vest in three equal installments on each of August 11, 2023, August 11, 2024 and August 11, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION